National Drug Schedules

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Benzoyl peroxide.	preparations of 5% or less as a single ingredient	U	MAY / 08
Benztropine or its salts^PDL	including but not limited to benzatropine	I	DEC / 13
Benzydamine or its salts^PDL		I	DEC / 13
Benzyl benzoate		II	SEP / 98
Bepotastine or its salts or derivatives^PDL		I	NOV / 16
Beractant^PDL		I	DEC / 13
Besifloxacin or its salts^PDL		I	DEC / 13
Betahistine or its salts^PDL		I	DEC / 13
Betaine or its salts^PDL	for human use, when sold or recommended for the treatment of homocystinuria	I	DEC / 13
Betaine or its salts.^PDL	for veterinary use	I	DEC / 13
Betaxolol or its salts^PDL		I	DEC / 13
Bethanechol chloride^PDL		I	DEC / 13
Bethanidine or its salts^PDL		I	DEC / 13
Bevacizumab^PDL		I	DEC / 13
Bezafibrate or its salts or derivatives^PDL		I	DEC / 13
Bicalutamide^PDL		I	DEC / 13
Bictegravir or its salts^PDL		I	AUG / 18
Bilastine or its salts or derivatives^PDL		I	AUG / 16
Binimetinib or its salts^PDL		I	MAY / 21
Biperiden or its salts^PDL		I	DEC / 13
Bisacodyl	when sold in strengths of 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl	U	JUL / 21
Bisacodyl	when sold in strengths of 5mg or less per oral dosage unit, in package sizes containing no more than 105 mg of bisacodyl	U	JUL / 21
Bisacodyl and its salts	(except when sold in strengths of 5mg or less per oral dosage unit in package sizes containing no more than 105mg of bisacodyl and except when sold in strengths of 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)	III	JUL / 21
Bishydroxycoumarin or its salts or derivatives^PDL		I	DEC / 13
Bisoprolol or its salts^PDL		I	DEC / 13
Bitolterol or its salts^PDL		I	DEC / 13
Bivalirudin^PDL		I	DEC / 13
Bleomycin^PDL		I	DEC / 13
Blinatumomab^PDL		I	AUG / 16
Boceprevir or its derivatives^PDL		I	DEC / 13
Boric acid and its salts	in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye]	II	DEC / 98
Bortezomib^PDL		I	DEC / 13
Bosentan or its salts or derivatives^PDL		I	DEC / 13
Bosutinib or its salts^PDL	including but not limited to Bosutinib methanoate	I	AUG / 14
Botulinum toxin^PDL	including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A	I	DEC / 13
Brentuximab vedotin^PDL		I	DEC / 13
Bretylium tosylate^PDL		I	DEC / 13
Brexpiprazole or its salts^PDL		I	APR / 17
Brexucabtagene autoleucel^PDL		I	JUL / 21
Brigatinib or its salts^PDL		I	AUG / 18
Brilliant Blue G or its derivatives^PDL		I	MAY / 21
Brimonidine or its salts^PDL		I	DEC / 13
Brivaracetam or its derivatives^PDL		I	AUG / 16
Brodalumab^PDL		I	MAY / 18
Brolucizumab^PDL		I	JUL / 20
Bromal^PDL		I	DEC / 13
Bromal hydrate^PDL		I	DEC / 13
Brometone^PDL		I	DEC / 13
Bromfenac or its salts^PDL		I	MAY / 15
Bromisoval^PDL		I	DEC / 13
Bromocriptine or its salts^PDL		I	DEC / 13
Bromoform^PDL		I	DEC / 13
Brompheniramine and its salts	as a single entity for the treatment of allergies	III	JAN / 03
Brompheniramine and its salts.	in combination products for the relief of cough and cold symptoms	U	JAN / 03
Buclizine		II	SEP / 98
Bufexamac		II	SEP / 98
Bumetanide or its salts or derivatives^PDL		I	DEC / 13
Bupivacaine and its salts	for topical use on mucous membranes except lozenges	III	SEP / 98
Bupivacaine and its salts	for parenteral or ophthalmic use	II	SEP / 98
Bupropion or its salts^PDL		I	DEC / 13
Burosumab^PDL		I	DEC / 18
Buserelin or its salts^PDL		I	DEC / 13
Buspirone or its salts^PDL		I	DEC / 13
Busulfan^PDL		I	DEC / 13
Butacaine and its salts	for ophthalmic or parenteral use	II	SEP / 98
Butaperazine or its salts^PDL		I	DEC / 13
Butenafine	1% cream	U	SEP / 99
Butoconazole or its salts^PDL		I	DEC / 13
Butorphanol and its salts ^C		I	JUN / 02
Butyl chloral hydrate^PDL		I	DEC / 13
Cabergoline or its salts^PDL		I	DEC / 13
Cabotegravir or its salts^PDL		I	JUL / 20
Cabozantinib or its salts^PDL		I	NOV / 18
Calcifediol^PDL		I	JUL / 18
Calcipotriol^PDL		I	DEC / 13
Calcitonin^PDL		I	DEC / 13
Calcitriol^PDL		I	DEC / 13
Calcium bromide^PDL		I	DEC / 13
Calcium bromolactobionate^PDL		I	DEC / 13
Calcium carbimide^PDL		I	DEC / 13
Calcium chloride in injectable form for parenteral nutrition		I	JAN / 03
Calcium disodium edetate		II	SEP / 98
Calcium gluconate in injectable form for parenteral nutrition		I	JAN / 03
Calcium polycarbophil		III	SEP / 98
Calcium salts when sold for the treatment of hyperphosphatemia^PDL		I	DEC / 13
Camphor	in oleaginous vehicles and in liquid forms in concentrations greater than 11%	II	OCT / 98
Canagliflozin^PDL		I	JUL / 14
Canakinumab^PDL		I	DEC / 13
Candesartan or its salts or derivatives^PDL	including but not limited to candesartan cilexetil	I	DEC / 13
Candicidin or its salts or derivatives^PDL		I	DEC / 13
Cantharides, their preparations and derivatives		II	SEP / 98
Caplacizumab^PDL		I	JUL / 20
Capreomycin or its salts or derivatives^PDL		I	DEC / 13
Captodiamine or its salts^PDL		I	DEC / 13
Captopril or its salts^PDL		I	DEC / 13
Carbachol^PDL		I	DEC / 13
Carbamazepine^PDL		I	DEC / 13
Carbapenem salts or derivatives^PDL	Including but not limited to: Doripenem, ertapenem, imipenem, meropenem	I	DEC / 18
Carbenoxolone or its salts^PDL		I	DEC / 13
Carbetocin or its salts^PDL		I	DEC / 13

1856 result(s)

Print Friendly Export to CSV

Footnotes

C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR - Drug has not been reviewed by the NDSAC
PDL - Drug is listed in the Health Canada Prescription Drug List
TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act

National Drug Schedules

Search: National Drug Schedules

1856 result(s)

Footnotes